Molecular Neurodegeneration Apolipoprotein E Levels in Cerebrospinal Fluid and the Effects of Abca1 Polymorphisms

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reply from the authors [4]

  2007cited by this paper
• Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease.

  2007cited by this paper
• Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice*

  2006cited by this paper
• The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo

  2006cited by this paper
• The Low Density Lipoprotein Receptor Regulates the Level of Central Nervous System Human and Murine Apolipoprotein E but Does Not Modify Amyloid Plaque Pathology in PDAPP Mice*

  2005cited by this paper
• Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice*

  2005cited by this paper
• Screening for functional sequence variations and mutations in ABCA1.

  2004cited by this paper
• Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study.

  2004cited by this paper
• ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE*

  2004cited by this paper
• Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β‐amyloid metabolism

  2004cited by this paper
• ApoE genotype accounts for the vast majority of AD risk and AD pathology.

  2004cited by this paper
• Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

  2004cited by this paper
• Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.

  2004cited by this paper
• Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain*

  2004cited by this paper
• Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.

  2003cited by this paper
• ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

  2003cited by this paper
• Differential metabolism of ApoE isoforms in plasma and CSF.

  2003cited by this paper
• APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

  2003cited by this paper
• Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1.

  2002cited by this paper
• Full genome screen for Alzheimer disease: stage II analysis.

  2002cited by this paper
• APOE genotype is a major predictor of long-term progression of disability in MS

  2001cited by this paper
• Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease

  2001cited by this paper
• Identification of novel genes in late-onset Alzheimer's disease.

  2000cited by this paper
• High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

  2000cited by this paper
• Common and rare ABCA1 variants affecting plasma HDL cholesterol.

  2000cited by this paper
• Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project.

  2000cited by this paper
• Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury.

  1999cited by this paper
• A full genome scan for late onset Alzheimer's disease.

  1999cited by this paper
• Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

  1998cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

  1998cited by this paper
• High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy

  1997cited by this paper
• Cerebral amyloid deposition and diffuse plaques in ``normal'' aging

  1996cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function.

  1988cited by this paper
• Validation of clinical diagnostic criteria for Alzheimer's disease

  1988cited by this paper
• Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

  1981cited by this paper

• Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes.

  2024cites this paper
• Association of ABCA1 R219K polymorphism and telomere length in a Chinese rural population: possible linking to systemic inflammation

  2023influential citation
• Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype

  2023cites this paper
• Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.

  2023cites this paper
• CLSPCOL rescues Alzheimer’s disease mouse models

  2022cites this paper
• Amyloid and Tau Pathology are Associated with Cerebral Blood Flow in Nondemented Older Adults with and without Vascular Risk Factors for Alzheimer's Disease

  2022cites this paper
• APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

  2022cites this paper
• Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease

  2022cites this paper
• Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1

  2021cites this paper
• Differences in Recycling of Apolipoprotein E3 and E4—LDL Receptor Complexes—A Mechanistic Hypothesis

  2021cites this paper
• Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer’s disease

  2021cites this paper
• The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease

  2021cites this paper
• FastCAT Accelerates Absolute Quantification of Proteins Using Multiple Short Nonpurified Chimeric Standards

  2021cites this paper
• Restoration of the reduced CLSP activity alleviates memory impairment in Alzheimer disease

  2021influential citation
• Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.

  2020cites this paper
• Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer’s Disease

  2020cites this paper
• Mechanisms of Microglia Mediated Apolipoprotien E Neurotoxicity

  2019cites this paper
• Higher Level of Mismatch in APOE ε4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid

  2019cites this paper
• Protective Variants in Alzheimer’s Disease

  2019cites this paper
• Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy

  2019cites this paper
• Administration of Downstream ApoE Attenuates the Adverse Effect of Brain ABCA1 Deficiency on Stroke

  2018cites this paper
• The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis

  2018cites this paper
• Effects of ABCA1 R219K Polymorphism and Serum Lipid Profiles on Mild Cognitive Impairment in Type 2 Diabetes Mellitus

  2017cites this paper
• Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes

  2016cites this paper
• Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease.

  2016cites this paper
• Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.

  2016cites this paper
• Alzheimer’s Disease Therapeutics Targeting Apolipoprotein E

  2016cites this paper
• The relevance of ABCA1 R219K polymorphisms and serum ABCA1 protein concentration to Parkinson’s disease pathogenesis and classification: a case–control study

  2016cites this paper
• Alzheimer's disease biomarkers detection in human samples by efficient capturing through porous magnetic microspheres and labelling with electrocatalytic gold nanoparticles.

  2015influential citation
• Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

  2015cites this paper
• Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease

  2015cites this paper
• Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?*

  2015cites this paper
• Lipids and Lipoproteins in Alzheimer’s Disease

  2015cites this paper
• Cerebrospinal Fluid Apolipoprotein E Concentration and Severity of Cognitive Impairment in Patients With Newly Diagnosed Alzheimer’s Disease

  2014cites this paper
• Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway*

  2014cites this paper
• Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease

  2014cites this paper
• CSF Apo-E levels associate with cognitive decline and MRI changes

  2014cites this paper
• ATP-binding cassette transporter A1: from metabolism to neurodegeneration.

  2014cites this paper
• Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor Processing

  2014cites this paper
• Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms.

  2014cites this paper
• Modulating Amyloid Beta Clearance by Altering Cellular and Whole Brain Apolipoprotein E Metabolism

  2014influential citation
• Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the RXR/RAR pathway

  2014cites this paper
• The Role of ABCA1 Gene Sequence Variants on Risk of Alzheimer's Disease

  2013cites this paper
• Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain

  2013cites this paper
• Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer’s Disease

  2013cites this paper
• Apolipoprotein E Isoforms Differentially Regulate Amyloid-β Stimulated Inflammation in Rat and Mouse Astrocytes

  2012cites this paper
• Meta-analysis on association between the ATP-binding cassette transporter A1 gene (ABCA1) and Alzheimer's disease.

  2012cites this paper
• Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift.

  2012cites this paper
• Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer’s disease

  2012cites this paper
• ABC Transporters and the Alzheimer’s Disease Enigma

  2012cites this paper
• In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS

  2012cites this paper
• Abca1 Deficiency Affects Alzheimer's Disease-Like Phenotype in Human ApoE4 But Not in ApoE3-Targeted Replacement Mice

  2012cites this paper
• A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration

  2012cites this paper
• The polymorphism of the ATP-binding cassette transporter 1 gene modulates Alzheimer disease risk in Chinese Han ethnic population.

  2012cites this paper
• Reduced levels of human apoE4 protein in an animal model of cognitive impairment.

  2011cites this paper
• Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.

  2011cites this paper
• The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.

  2010cites this paper
• Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.

  2010cites this paper
• Identification and Functional Characterization of Genetic Risk Factors in Alzheimer´s Disease

  2009cites this paper
• The role of apolipoprotein E in Alzheimer's disease.

  2009cites this paper
• Multiple SNPs Within and Surrounding the Apolipoprotein E Gene Influence Cerebrospinal Fluid Apolipoprotein E Protein Levels

  2008influential citation
• Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease

  2008cites this paper
• ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro

  2008cites this paper